Clinical Trial Update: Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Brimonidine Purite 0.15% versus Dorzolamide 2% as adjuncts to latanoprost in glaucoma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Brimonidine Purite 0.15% (brimonidine)
• Dorzolamide 2% (dorzolamide)

Snippet

Sponsor: Innovative Medical | Conditions: Glaucoma | Phase 4 | Status: COMPLETED